AI Engines For more Details: Perplexity Kagi Labs You
Reduction of Triglycerides: Gemfibrozil is effective in lowering triglyceride levels in the blood. High triglyceride levels are associated with an increased risk of cardiovascular disease.
Increase in HDL Cholesterol: Gemfibrozil can also raise high-density lipoprotein (HDL) cholesterol levels, often referred to as "good" cholesterol. HDL helps remove low-density lipoprotein (LDL) cholesterol from the arteries, reducing the risk of atherosclerosis and cardiovascular disease.
Decrease in LDL Cholesterol: While gemfibrozil primarily targets triglycerides and HDL cholesterol, it may also modestly reduce low-density lipoprotein (LDL) cholesterol levels, commonly known as "bad" cholesterol.
Cardiovascular Risk Reduction: By lowering triglycerides and increasing HDL cholesterol levels, gemfibrozil can help reduce the risk of cardiovascular events such as heart attacks and strokes, particularly in individuals with hypertriglyceridemia.
Improvement in Lipid Profile: Gemfibrozil treatment often results in an overall improvement in lipid profile, characterized by lower triglyceride levels, higher HDL cholesterol levels, and sometimes modest reductions in LDL cholesterol.
Prevention of Pancreatitis: High triglyceride levels are a risk factor for pancreatitis (inflammation of the pancreas). By lowering triglyceride levels, gemfibrozil may help reduce the risk of pancreatitis in susceptible individuals.
Potential Side Effects: Common side effects of gemfibrozil include gastrointestinal symptoms such as abdominal pain, diarrhea, nausea, and indigestion. Some individuals may also experience muscle pain or weakness, which can be a sign of myopathy or rhabdomyolysis (muscle breakdown). These side effects are usually reversible upon discontinuation of the medication.
Interactions with Other Medications: Gemfibrozil can interact with certain medications, including statins (cholesterol-lowering drugs), leading to an increased risk of myopathy or rhabdomyolysis. It is important to consult a healthcare professional before starting gemfibrozil if taking other medications.
Liver Function Monitoring: Gemfibrozil may affect liver function, and periodic monitoring of liver enzymes may be necessary during treatment, particularly in individuals with pre-existing liver conditions.
Contraindications: Gemfibrozil is contraindicated in individuals with severe liver or kidney disease, gallbladder disease, or a history of hypersensitivity to the medication.
Long-Term Use: The long-term safety and efficacy of gemfibrozil have been established in numerous clinical trials. However, like any medication, it should be used with caution, and regular monitoring may be necessary, especially in individuals with multiple risk factors for cardiovascular disease.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium adolescentis | Reduces |
species | Bifidobacterium bifidum | Reduces |
species | Bifidobacterium breve | Reduces |
species | Bifidobacterium catenulatum | Reduces |
species | Bifidobacterium longum | Reduces |
species | Christensenella minuta | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Parabacteroides distasonis | Reduces |
species | Veillonella atypica | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Odoribacter | genus | Decreases |
0 | 1 | Clostridioides | genus | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Clostridium | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Alistipes | genus | Decreases |
0 | 1 | Coprobacter | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Thomasclavelia | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 1 | Clostridium perfringens A | no rank | Decreases |
0 | 1 | Clostridium perfringens B | no rank | Decreases |
0 | 1 | Clostridium perfringens C | no rank | Decreases |
0 | 1 | Clostridium perfringens CPE | no rank | Decreases |
0 | 1 | Clostridium perfringens D | no rank | Decreases |
0 | 1 | Clostridium perfringens E | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Bacteroides caccae | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
1 | 0 | Bifidobacterium adolescentis | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
1 | 0 | Clostridioides difficile | species | Decreases |
1 | 0 | Odoribacter splanchnicus | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Roseburia hominis | species | Decreases |
1 | 0 | Bacteroides ovatus | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
0 | 1 | Streptococcus sp. HSISM1 | species | Decreases |
0 | 1 | Streptococcus sp. LPB0220 | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Veillonella rodentium | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Clostridium perfringens | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Dorea formicigenerans | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
0 | 1 | Bifidobacterium breve | species | Decreases |
0 | 1 | Veillonella dispar | species | Decreases |
0 | 1 | Bifidobacterium angulatum | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
0 | 1 | Veillonella sp. S12025-13 | species | Decreases |
0 | 1 | Bacteroides sp. D2 | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Veillonella nakazawae | species | Decreases |
0 | 1 | Bacteroides humanifaecis | species | Decreases |
0 | 1 | Bacteroides sp. M10 | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Veillonella rogosae | species | Decreases |
0 | 1 | Coprobacter secundus | species | Decreases |
0 | 1 | Butyricimonas faecalis | species | Decreases |
0 | 1 | Bacteroides sp. A1C1 | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Bacteroides sp. CACC 737 | species | Decreases |
0 | 1 | Alistipes megaguti | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Streptococcus lactarius | species | Decreases |
0 | 1 | uncultured Alistipes sp. | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Butyricimonas virosa | species | Decreases |
0 | 1 | Bifidobacterium catenulatum | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Veillonella atypica | species | Decreases |
0 | 1 | Coprobacter fastidiosus | species | Decreases |
0 | 1 | Parolsenella catena | species | Decreases |
0 | 1 | Coprococcus comes | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Alistipes sp. dk3624 | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Alistipes onderdonkii | species | Decreases |
0 | 1 | Bifidobacterium bifidum | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Streptococcus salivarius | species | Decreases |
0 | 1 | Alistipes ihumii | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Alistipes finegoldii | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Alistipes senegalensis | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Alistipes dispar | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Streptococcus sp. FDAARGOS_192 | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Streptococcus australis | species | Decreases |
0 | 1 | Alistipes communis | species | Decreases |
0 | 1 | Alistipes shahii | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Parabacteroides merdae | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Amedibacterium intestinale | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Streptococcus infantis | species | Decreases |
0 | 1 | Bacteroides nordii | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Parolsenella massiliensis | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Barnesiella viscericola | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 061 | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
1 | 0 | Thomasclavelia ramosa | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Acne | 0.4 | -0.4 | |
ADHD | 3.7 | 0.4 | 8.25 |
Age-Related Macular Degeneration and Glaucoma | 0.5 | 0 | 0 |
Allergic Rhinitis (Hay Fever) | 1.5 | 2.6 | -0.73 |
Allergies | 4.7 | 2.3 | 1.04 |
Allergy to milk products | 0.9 | 0.8 | 0.13 |
Alopecia (Hair Loss) | 0.6 | 0.6 | |
Alzheimer's disease | 4.7 | 4 | 0.18 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1.9 | 0.4 | 3.75 |
Ankylosing spondylitis | 2.2 | 0.6 | 2.67 |
Anorexia Nervosa | 1.1 | 1.7 | -0.55 |
Antiphospholipid syndrome (APS) | 0.2 | 0.2 | |
Asthma | 3.8 | 2.5 | 0.52 |
Atherosclerosis | 1.4 | 1.2 | 0.17 |
Atrial fibrillation | 1.9 | 0.8 | 1.37 |
Autism | 5.5 | 5.2 | 0.06 |
Autoimmune Disease | 0.6 | 0.8 | -0.33 |
Barrett esophagus cancer | 0.6 | 0.2 | 2 |
benign prostatic hyperplasia | 0 | 0.2 | 0 |
Biofilm | 1.6 | 1.6 | |
Bipolar Disorder | 0.6 | 0.6 | 0 |
Brain Trauma | 0.9 | 0.9 | 0 |
Breast Cancer | 0.7 | 0.7 | |
Cancer (General) | 0.9 | 2.4 | -1.67 |
Carcinoma | 3 | 1.7 | 0.76 |
Celiac Disease | 1.9 | 2.6 | -0.37 |
Cerebral Palsy | 1.4 | 0.7 | 1 |
Chronic Fatigue Syndrome | 3.4 | 3.4 | 0 |
Chronic Kidney Disease | 2.6 | 1.2 | 1.17 |
Chronic Lyme | 0.6 | 0.5 | 0.2 |
Chronic Obstructive Pulmonary Disease (COPD) | 1.3 | 1.1 | 0.18 |
Chronic Urticaria (Hives) | 0.7 | 0.6 | 0.17 |
Coagulation / Micro clot triggering bacteria | 0.3 | 0.7 | -1.33 |
Cognitive Function | 1.1 | 1.4 | -0.27 |
Colorectal Cancer | 4.1 | 1.3 | 2.15 |
Constipation | 0.3 | 0.5 | -0.67 |
Coronary artery disease | 0.6 | 1.8 | -2 |
COVID-19 | 7.1 | 7.4 | -0.04 |
Crohn's Disease | 4.5 | 3.5 | 0.29 |
Cushing's Syndrome (hypercortisolism) | 0.2 | -0.2 | |
cystic fibrosis | 0.1 | 1.7 | -16 |
d-lactic acidosis (one form of brain fog) | 0 | 0 | |
deep vein thrombosis | 1.1 | 0.7 | 0.57 |
Denture Wearers Oral Shifts | 1.5 | 1.5 | |
Depression | 6.8 | 5.2 | 0.31 |
Dermatomyositis | 0.2 | 0.4 | -1 |
Eczema | 0.9 | 1.6 | -0.78 |
Endometriosis | 1.3 | 1 | 0.3 |
Eosinophilic Esophagitis | 0.3 | 0.5 | -0.67 |
Epilepsy | 2.6 | 1.6 | 0.63 |
erectile dysfunction | 0.7 | 0.5 | 0.4 |
Fibromyalgia | 1.7 | 1.2 | 0.42 |
Functional constipation / chronic idiopathic constipation | 2.9 | 2.6 | 0.12 |
gallstone disease (gsd) | 1.1 | 1.2 | -0.09 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.4 | 1.3 | 0.08 |
Generalized anxiety disorder | 1.4 | 1.7 | -0.21 |
giant cell arteritis | 0.1 | -0.1 | |
Glioblastoma | 0.2 | -0.2 | |
Gout | 1.2 | 0.3 | 3 |
Graves' disease | 1.1 | 2.1 | -0.91 |
Gulf War Syndrome | 0.6 | 1.2 | -1 |
Halitosis | 1.6 | 0.2 | 7 |
Hashimoto's thyroiditis | 2.7 | 1.1 | 1.45 |
Heart Failure | 2.1 | 1.2 | 0.75 |
hemorrhagic stroke | 0.6 | 0.6 | |
Hidradenitis Suppurativa | 0.8 | 0.3 | 1.67 |
High Histamine/low DAO | 0.7 | 0.4 | 0.75 |
hypercholesterolemia (High Cholesterol) | 0.5 | 0.4 | 0.25 |
hyperglycemia | 0.8 | 1.5 | -0.88 |
Hyperlipidemia (High Blood Fats) | 0.8 | 0.3 | 1.67 |
hypersomnia | 0.4 | -0.4 | |
hypertension (High Blood Pressure | 2.5 | 4.3 | -0.72 |
Hypothyroidism | 0.2 | 0.8 | -3 |
Hypoxia | 1.3 | 1.3 | |
IgA nephropathy (IgAN) | 0.9 | 3 | -2.33 |
Inflammatory Bowel Disease | 5.7 | 6 | -0.05 |
Insomnia | 1.3 | 1.9 | -0.46 |
Intelligence | 1 | 1 | |
Intracranial aneurysms | 0.8 | 0.2 | 3 |
Irritable Bowel Syndrome | 5.1 | 3.4 | 0.5 |
ischemic stroke | 2.1 | 0.5 | 3.2 |
Liver Cirrhosis | 4.4 | 2.8 | 0.57 |
Long COVID | 4.2 | 5.1 | -0.21 |
Low bone mineral density | 0.7 | -0.7 | |
Lung Cancer | 0.7 | 1 | -0.43 |
Lymphoma | 0 | 0.2 | 0 |
Mast Cell Issues / mastitis | 0.8 | 0.5 | 0.6 |
ME/CFS with IBS | 0.6 | 1.9 | -2.17 |
ME/CFS without IBS | 0.8 | 1.2 | -0.5 |
membranous nephropathy | 0.2 | 0.2 | |
Menopause | 2.2 | 0.5 | 3.4 |
Metabolic Syndrome | 4.4 | 6 | -0.36 |
Mood Disorders | 7.9 | 4.2 | 0.88 |
multiple chemical sensitivity [MCS] | 0.8 | 0.3 | 1.67 |
Multiple Sclerosis | 4.3 | 2.7 | 0.59 |
Multiple system atrophy (MSA) | 1.5 | 0.7 | 1.14 |
myasthenia gravis | 0.2 | 0.4 | -1 |
neuropathic pain | 0.1 | 2.2 | -21 |
Neuropathy (all types) | 0.8 | 0.9 | -0.13 |
neuropsychiatric disorders (PANDAS, PANS) | 0.6 | 0.6 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3 | 4.2 | -0.4 |
NonCeliac Gluten Sensitivity | 1.5 | 0.6 | 1.5 |
Obesity | 6.7 | 5.6 | 0.2 |
obsessive-compulsive disorder | 3.5 | 2.2 | 0.59 |
Osteoarthritis | 1.6 | 1.1 | 0.45 |
Osteoporosis | 1 | 1.5 | -0.5 |
pancreatic cancer | 1.2 | 0.2 | 5 |
Parkinson's Disease | 5.4 | 3.3 | 0.64 |
Peanut Allergy | 0.1 | -0.1 | |
Polycystic ovary syndrome | 2.9 | 2.1 | 0.38 |
Postural orthostatic tachycardia syndrome | 0.1 | 0.5 | -4 |
Premenstrual dysphoric disorder | 0.8 | 0 | 0 |
primary biliary cholangitis | 0.6 | 1.2 | -1 |
Primary sclerosing cholangitis | 2.3 | 1.3 | 0.77 |
Psoriasis | 2.3 | 1.1 | 1.09 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 3.9 | 2.8 | 0.39 |
Rosacea | 0.6 | 0.4 | 0.5 |
Schizophrenia | 5.4 | 1.8 | 2 |
scoliosis | 0.2 | 0.2 | 0 |
sensorineural hearing loss | 0.1 | 0.1 | |
Sjögren syndrome | 1.9 | 2.1 | -0.11 |
Sleep Apnea | 1.1 | 1 | 0.1 |
Slow gastric motility / Gastroparesis | 0.5 | 0.4 | 0.25 |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.2 | 0.6 | 1 |
Stress / posttraumatic stress disorder | 1.7 | 1.7 | 0 |
Systemic Lupus Erythematosus | 2.2 | 1.8 | 0.22 |
Tic Disorder | 0.6 | 1 | -0.67 |
Tourette syndrome | 0.5 | 0.2 | 1.5 |
Type 1 Diabetes | 2.3 | 2.9 | -0.26 |
Type 2 Diabetes | 4.6 | 4.3 | 0.07 |
Ulcerative colitis | 3.1 | 4.6 | -0.48 |
Unhealthy Ageing | 3.1 | 1.5 | 1.07 |
Vitiligo | 1.2 | 1 | 0.2 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]